What makes your innovation unique?
SVAN is the first fully automatic intraosseous bone drill for newborns and premature babies. With precise wrist control, safety stop and bone marrow detection, it minimises the risk of injury and has the potential to reduce neonatal mortality by 30%. The impact is extensive since 1.5 million babies are faced with this emergency every year.
Advantages
• The technology automatically recognises bone marrow.
• It is unrivalled in terms of safety and accuracy.
• The patented innovation promotes sustainable health goals and saves lives.
Awards
• Winner of the "3D Printing in Life Sciences Award" – 2024
• Best Start-Up at IECT Hermann Hauser Summer School – 2024
• Winner and invitation to the Falling Walls Science Summit – 2024
• Best Pitch for Business Idea at the xbio-Demo Day, XISTA Science Ventures – 2024
About the company
SVAN, a spin-off of the Medical University of Vienna, has been funded by the FFG programme since 2024. With patent-protected technology, animal testing, ethics approval and CE marking, the company is to be established in 2025. Exclusive licences, production, sales and cooperation with investors and customers are envisaged.
